Efficacy of Portable Fugitive Aerosol Mitigation Systems for Nebulizer Therapy During High-Flow Nasal Cannula and Non-Invasive Ventilation
Authors:
- Adithya Shyamala PandianAPAdithya Shyamala Pandian
- Bhavesh PatelBPBhavesh Patel
- Karam Abi KaramKKKaram Abi Karam
- Amelia LowellALAmelia Lowell
- Kelly McKayKMKelly McKay
- Sabrina Jimena MoraSMSabrina Jimena Mora
- Piyush HotaPHPiyush Hota
- Gabriel PyznarGPGabriel Pyznar
- Sandra BatchelorSBSandra Batchelor
- Charles PeworskiCPCharles Peworski
- David RivasDRDavid Rivas
- Devang SanghaviDSDevang Sanghavi
Open Access
- 29 July 2025
- journal article
- research article
- Published by MDPI AG in Emergency Care and Medicine
- Vol. 2 (3) , 36
Abstract
Objectives: This study evaluates the efficacy of existing and new aerosol mitigation methods during nebulization (Neb) in combination with high-flow nasal cannula (HFNC) oxygen supplementation and non-invasive ventilation (NIV). Methods: We recorded fugitive aerosol particle concentrations over time and assessed the peak (P) and area (A) efficacy of active and passive mitigation methods, comparing them to a no-mitigation condition. Peak efficacy was measured by the reduction in maximum aerosol concentration, while area efficacy was quantified by the reduction of the area under the aerosol concentration–time curve. Results: For HFNC with Neb, we found that active mitigation using a mask with a biofilter and a fan (referred to as the aerosol barrier mask) significantly outperformed passive mitigation with a face mask. The peak and area efficacy for aerosol reduction were 99.0% and 96.4% for active mitigation and 35.9% and 7.6% for passive mitigation, respectively. For NIV with Neb, the active mitigation method, using a box with a biofilter and fan, also outperformed passive mitigation using only the box. The peak and area efficacy for aerosol reduction were 92.1% and 85.5% for active mitigation and 53.7.0% and 25.4% for passive mitigation, respectively. Conclusion: We concluded that active mitigation set up systems advantageous for effective reduction of airborne aerosols during aerosol generated procedures.Keywords
Funding Information
- NIH-NIBIB (5R03EB027336)
- ASU’s PLUS Alliance
- ASU’s Ira Fulton Schools of Engineering
- NSF- Partnership for Innovation (2122901)
- A.J. and Sigismunda Palumbo Charitable Trust
- Mayo Clinic—Arizona State University Health Alliance
This publication has 47 references indexed in Scilit:
- Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer ConsortiumChest, 2023
- Case-control study evaluating risk factors for SARS-CoV-2 outbreak amongst healthcare personnel at a tertiary care centerAmerican Journal of Infection Control, 2021
- Update efficacy of aerosol therapy with noninvasive ventilator approach (non-invasive ventilation and nasal high flow)Journal of Drug Delivery Science and Technology, 2020
- Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomyEnvironmental Research, 2020
- Airborne route and bad use of ventilation systems as non-negligible factors in SARS-CoV-2 transmissionMedical Hypotheses, 2020
- Review of indoor aerosol generation, transport, and control in the context of COVID‐19International Forum of Allergy & Rhinology, 2020
- Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sitesActa Pharmaceutica Sinica B, 2020
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host responseDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Management of Aerosol during Noninvasive Ventilation for Patients with Sleep-Disordered Breathing: Important Messages during the COVID-19 PandemicSleep and Vigilance, 2020
- Intensive care unit isolation hood decreases risk of aerosolization during noninvasive ventilation with COVID-19Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2020